Background: Hodgkin lymphoma in young adults is inexplicably linked to economic development.

Methods: We conducted a nested case–control study of the 656 servicemen with Hodgkin lymphoma diagnosed between ages 17 to 32 while on active duty in the U.S. military during 1950–68. Controls, chosen randomly from the servicemen on duty at the time, were matched on service, birth year, and induction date. Information came from preinduction records and military records for the period ending at onset or the equivalent date.

Results: Risk was independently increased with small sib-ship size [OR, 2.3; confidence interval (CI), 1.6–3.5], low birth order (OR, 1.9; CI, 1.4–2.6), and an interval of at least 5 years between birth and that of a previous or subsequent sibling (OR, 2.1; CI, 1.5–3.1). Other factors independently and significantly associated with elevated risk of Hodgkin lymphoma were: tallness, high body mass index, more education (but not higher income) in the county of birth, BB or AB blood type, and past infectious mononucleosis (but a deficit of other childhood viral infections). Early fatherhood conveyed high risk (OR, 2.6; CI, 1.4–4.8), especially if with a high-risk sibling configuration. Factors unrelated to risk included personal education, preinduction or military occupation, induction test score, and rank. Findings were similar for nodular sclerosis and mixed cell histologic subtypes.

Conclusions: Protection from the environment in childhood, but not in adulthood, increases the likelihood of young adult Hodgkin lymphoma, which may result from nonspecific isolation from early infections and/or exposure to late infection by a specific but unidentified ubiquitous childhood virus.

Impact: Events in childhood protect against later Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev; 24(11); 1707–15. ©2015 AACR.

Hodgkin lymphoma is a neoplasm with three modes in age-specific incidence: childhood, old age, and during adolescence and young adulthood. In 1957, MacMahon (1) concentrated on the young adult mode, and recognized an internationally variable trend in incidence (2, 3), with a link between population-specific rates of incidence and economic development that suggests an acquired determination. He further recognized the distinctive immunologic characteristics of the disease (4), and listed factors that distinguished these cases from cases among older persons: a sex ratio nearer unity, presentation above the diaphragm, longer survival, and usually nodular sclerosis histology (5). Pathologists have long distinguished diverse histologic subcategories (6), and the nodular sclerosis subgroup is characterized by very sparsely distributed malignant cells, multinucleated Hodgkin and Reed–Sternberg (HRS) cells, surrounded by diverse hematopoetic cells and wide bands of fibrosis. This condition has now been designated by consensus as adolescent/young adult Hodgkin lymphoma (AYAHL; refs. 7, 8). Although in 1994, AYAHL cases were classified by pathologists on clinical and immunophenotypic grounds in combination with older mixed cellularity cases as “classic” Hodgkin lymphoma (9, 10), Weiss and colleagues (11) subsequently validated the earlier etiologic dichotomy by demonstrating antigens of Epstein–Barr virus (EBV) in the nuclei of HRS cells in the tumors of most older cases but not in those of most AYAHL cases (12–14).

Accumulating evidence now indicates a strong genetic susceptibility to AYAHL: incidence is linked to race and specific HLA haplotypes (15), occurrence is high among the relatives (16), siblings (17, 18), and especially the identical co-twins (19) of cases, and genome-wide association studies suggest specific HLA, cytokine, T-helper type 2 (Th2), and B-cell differentiation pathways, modified in those cases positive for EBV (20). Empirically, immunologic characteristics such as a Th2-skewed immune response are present at diagnosis and have been found to predict risk (4, 21, 22). Interest in heritable determinants has now diverted attention from acquired determinants (23).

However, whether defined by age, nodular sclerosis histology, or the absence of EBV antigens, the incidence of AYAHL continues to increase with changes in economic status, both in developed (24–26) and developing (27–29) countries. Although registry-based descriptions and analytic studies repeatedly show a socioeconomic gradient (24, 30), it has been unclear which particular attributes of social class are responsible, and whether the social status at diagnosis represents the prediagnosis status or that of the childhood environment.

Here, we propose to further elucidate the age-specific environmental determination of AYAHL. Speculation about the nature of acquired determinant(s) has focused on two possibilities that are not mutually exclusive and may even be additive. Although searches have proved fruitless (31), an infectious viral determinant was first suggested by the histologic and clinical pattern (32), and by analogy with the carcinogenetic actions of herpes viruses in chickens and primates (33, 34), the age pattern of paralytic polio (34), and the occurrence of EBV-associated lymphomas among the immune-compromised (35). Alternatively, long-term immunologic susceptibility to an infection or other exposure might cluster among those persons who had been isolated in early life from the environmental exposures and microbial infections required for normal immune development.

Well-controlled analytic studies of a disease as uncommon as AYAHL have been limited in number and size. Cohort investigations necessarily enroll few youthful subjects, and case–control power considerations often favor the inclusion of older and etiologically disparate cases (36). Appropriate attention to the environmental exposures or even social class in childhood rarely has been feasible using conventional methods of data collection (37, 38).

This report describes a very large case–control study nested in a defined population and conducted under particularly advantageous conditions. All cases appearing among young men after induction into the U.S. military during a period of universal conscription and diagnosed under uniform clinical conditions were ascertained and compared with individually matched healthy conscripts from the same period on the basis of information recorded prior to diagnosis.

This protocol was reviewed and approved for the protection of human subjects by the Department of Defense and the National Research Council. Rosters of the service numbers of all men diagnosed with confirmed Hodgkin lymphoma while on active duty were provided by the offices of the U.S. Military Surgeons General. Cases were ascertained from the Navy during 1950–1967, from the Army during 1951–1964, and from the Air Force during 1958–1968. Eligibility required each case to have at least one year of service before symptom onset and to have been diagnosed before age 32, and each to be verified in records at the National Personnel Records Center (NPRC) in St. Louis. The date of onset was assigned by medical abstractors in consultation with one of us (TMM) using the following criterion: the first appearance of any symptom other than weight loss in the illness episode leading to the diagnosis. Cases with symptom onset before service entry were excluded.

Initially 1,568 service numbers on separate rosters (Navy, Army, and Air Force) were identified as potential cases. Five hundred and sixty-two exclusions were made on the basis of disease rubric, preservice onset, age at diagnosis, length of service eligibility, or duplicate service number, reducing the total to 1,006. Of these, 14 could not be linked to a service record, and 82 records could not be located at NPRC. Of the remaining 910 cases, 201 ultimately proved ineligible on the basis of age at diagnosis or length of service. Controls were sought for the remaining 709 cases by matching in sequence on branch of service, birth date (±1 calendar year), date of entry into active duty (EAD; ±6 months), and length of service (see below) from a roster assembled to comprise a representative cross-section of those on duty during each year of potential diagnosis, that is, 1950 through 1970. Because no rosters based on year-specific active duty existed, this roster was created by combining a 1% sample of all separations between June 1, 1955 and December 31, 1970; a 1% sample of all service personnel still on active duty at the cutoff date: in the Army on December 31, 1970, or in the Navy or Air Force on June 30, 1971, and a 0.1% sample of all discharges and other separations from service between July 1, 1950 and October 31, 1955 (the two sampling fractions differing because this period witnessed the demobilization of a very large number of troops after the Korean conflict).

Because the military and medical careers of Hodgkin lymphoma cases are inevitably affected by disease, a cutoff reference date was established; the day of hospitalization during which Hodgkin lymphoma was first confirmed for each case, and the day which terminated an equivalent length of active service for each matched control.

In the summer of 1973, after service records for three fourths of the controls had been identified and removed for abstraction, a fire at the NPRC in St. Louis destroyed over 80% of all filed records of eligible Army and Air Force personnel, including those of the controls who had been identified but whose records had not been removed. Fortunately, the records filed (by service number) in the bottom drawers of each of the dozens of file cabinets burned in the fire were soaked by fire-hoses before destruction, and could be salvaged by freeze drying. The controls whose records had been destroyed were then replaced (using the original eligibility and matching criteria) by random selection from the sampling frame of the combined contents of the bottom drawers, which provided a representative cluster sample (by service number) of the original complete set of files. In the end, appropriate matched controls were found for all but 53 cases. Thus 656 population-based cases (92.5% of those eligible) and the matched controls form the basis for this report.

The experiences and characteristics of each subject were gathered from four sources: the induction and enlistment records; the physical examination and medical history forms completed at the time of service entry; the medical records (outpatient entries and inpatient clinical records) generated during service before the established reference date; and the non-medical service records covering the period of service before the reference date. Items descriptive of antecedent experience with general biologic significance, validity, and consistency were abstracted and are grouped as follows.

Preservice demography and geography

Date and county of birth, date and residential address and county at induction (urban or rural), length of preinduction education in years, civilian occupation, religion, race, Hispanic or other ethnicity (deduced from surname; ref. 39), number and ages of siblings, parental age, and marital/parental status at service entry, meteorological and geographical characteristics of U.S. counties in 1959 (40). Counties were divided into quartiles on the basis of 1950 Hodgkin lymphoma mortality rates (41) to examine the effects of preinduction migration between counties at disparate levels of risk.

Physical examination and prior medical history at induction

Family history of (unspecified) cancer or asthma, height and weight, ABO blood type, color vision status, eye color, handedness, history, hay-fever, asthma, childhood infections, infectious mononucleosis, sexually transmitted diseases, tuberculosis, appendectomy, tonsillectomy.

Service experience

Service aptitude test score, rank at reference date, assignment to a medical unit, to duty entailing X-ray or radar exposure, to duty entailing food preparation or handling, or to combat duty.

History of AYAHL

Clinical date of onset and pathologic confirmation were obtained from records linked to those on file at the Armed Forces Institute of Pathology. Each diagnostic specimen was categorized using the modified Lukes system (42) into nodular sclerosis (ND), lymphocyte predominant (LP), lymphocyte depleted (LD), and mixed cellularity (MC).

The abstraction of all records, data entry, and data quality control were completed by September of 1974.

Statistical analyses

The variables were screened using matched pair comparisons after reducing variables measured on a continuous or expanded ordinal scale into succinct ordinal categories. Conventional univariate matched pair estimates of the relative risk for each individual variable were then calculated. All factors found or expected to significantly influence the risk of AYAHL were then reanalyzed using multivariate logistic regression using Epilog (Epicenter Software) producing a risk estimate with 95% confidence interval (CI) for each variable after adjustment for all other variables.

Sibling configuration

Several characteristics of the sib-ship were independent predictors of diagnosis (Table 1). Risk was linked to lower sib-ship size, diminishing stepwise with each additional sibling (Fig. 1). Risk was also predicted by earlier birth order and by the interval between birth and that of the next youngest or oldest sibling. Table 2 combines sib-ship size, birth order and these intervals, indicating that no single characteristic is wholly responsible. Maternal age was not significantly associated with AYAHL (not shown).

Figure 1.

Univariate OR of AYA Hodgkin lymphoma in the military according to sib-ship size.

Figure 1.

Univariate OR of AYA Hodgkin lymphoma in the military according to sib-ship size.

Close modal
Table 1.

Overall impact of sibling configuration: sib-ship size, birth order, interval in age from nearest sibs

VariableCategoryCA/COReferentCA/COOR UNIVCI
Sib-ship size 1 (only child) 103/60 >3 (OR, 1.0) 121/121 2.3 1.6–3.5 
Sib-ship size 2–3 265/245 >3 (OR, 1.0) 121/121 1.4 1.1–1.9 
Birth order First-borne 304/219 Middle-borne (OR, 1.0) 132/178 1.9 1.4–2.6 
Birth order Last-borne 123/127 Middle-borne (OR, 1.0) 132/178 1.3 0.93–1.8 
Interval between case and sibling births Number of sibs born within 5 y of case 225/154 Younger and older sibs born within 5 y of case (OR, 1.0) 92/136 2.1 1.5–3.0 
Interval between case and sibling births Younger sibs, none born within 5 y of case 150/142 Younger and older sibs born within 5 y of case (OR, 1.0) 92/136 1.6 1.1–2.2 
Interval between case and sibling births Older sibs, none born within 5 y of case 110/111 Younger and older sibs born within 5 y of case (OR, 1.0) 92/136 1.5 1.0–2.2 
VariableCategoryCA/COReferentCA/COOR UNIVCI
Sib-ship size 1 (only child) 103/60 >3 (OR, 1.0) 121/121 2.3 1.6–3.5 
Sib-ship size 2–3 265/245 >3 (OR, 1.0) 121/121 1.4 1.1–1.9 
Birth order First-borne 304/219 Middle-borne (OR, 1.0) 132/178 1.9 1.4–2.6 
Birth order Last-borne 123/127 Middle-borne (OR, 1.0) 132/178 1.3 0.93–1.8 
Interval between case and sibling births Number of sibs born within 5 y of case 225/154 Younger and older sibs born within 5 y of case (OR, 1.0) 92/136 2.1 1.5–3.0 
Interval between case and sibling births Younger sibs, none born within 5 y of case 150/142 Younger and older sibs born within 5 y of case (OR, 1.0) 92/136 1.6 1.1–2.2 
Interval between case and sibling births Older sibs, none born within 5 y of case 110/111 Younger and older sibs born within 5 y of case (OR, 1.0) 92/136 1.5 1.0–2.2 

Abbreviations: CA/CO, #cases/#controls; OR UNIV, univariate OR.

Table 2.

Detailed impact of sibling configuration with and without adjustment: birth order by sib-ship size/interval in age from nearest sibs (“close” = within 5 years)

CategoryCA/COReferentCA/CO (OR, 1)OR UNIVOR ADJaADJ CI
Only child 103/60 Middle of >3, <5 y between births 62/102 2.7 3.0 1.8–4.9 
First of 2–3, >4 y before next birth 75/62 Same as above As above 3.4 3.6 1.9–6.5 
First of 2–3, <5 y before next birth 57/28 Same as above As above 2.2 2.0 1.2–3.4 
First of >3, >4 y before next birth 11/11 Same as above As above 2.2 2.4 0.83–7.0 
First of >3, <5 y before next birth 58/58 Same as above As above 1.9 1.8 1.0–3.1 
Last of 2–3, >4 y after previous birth 35/30 Same as above As above 1.6 1.8 0.94–3.6 
Last of 2–3, <5 y after previous birth 48/53 Same as above As above 1.6 1.7 0.94–2.9 
Last of >3, >4 y after previous birth 11/15 Same as above As above 1.4 1.4 0.53–3.6 
Last of >3, <5 y after previous birth 29/29 Same as above As above 1.8 1.7 0.83–3.6 
Middle of 3, >4 y between sib births 2/6 Same as above As above 0.4 0.7 0.12–3.6 
Middle of 3, <5 y before next, >4 y after previous sib birth 4/5 Same as above As above 1.3 1.6 0.37–6.8 
Middle of 3, <5 y after previous, >4 y before next sib birth 15/10 Same as above As above 2.1 2.2 0.81–5.7 
Middle of 3, <5 y between sib births 12/15 Same as above As above 1.4 1.4 0.55–3.8 
Middle of 3, unknown birth order 17/36 Same as above As above 0.66 0.7 0.34–1.6 
Middle of >3, >4 y between births 6/4 Same as above As above 2.8 2.5 0.64–9.9 
Middle of >3, <5 y before next, >4 y after previous birth 13/17 Same as above As above 1.2 1.2 0.52–2.8 
Middle of >3, <5 y after previous, >4 yrs before next birth 18/19 Same as above As above 1.3 1.2 0.47–2.8 
Middle of >3, unknown birth order 17/31 Same as above As above 0.82 0.9 0.41–1.8 
>6, Unknown sib-ship structure 18/19 Same as above As above 1.7 1.9 0.87–4.1 
Unknown sib-ship size 45/46 Same as above As above 1.7 1.3 0.59–2.7 
CategoryCA/COReferentCA/CO (OR, 1)OR UNIVOR ADJaADJ CI
Only child 103/60 Middle of >3, <5 y between births 62/102 2.7 3.0 1.8–4.9 
First of 2–3, >4 y before next birth 75/62 Same as above As above 3.4 3.6 1.9–6.5 
First of 2–3, <5 y before next birth 57/28 Same as above As above 2.2 2.0 1.2–3.4 
First of >3, >4 y before next birth 11/11 Same as above As above 2.2 2.4 0.83–7.0 
First of >3, <5 y before next birth 58/58 Same as above As above 1.9 1.8 1.0–3.1 
Last of 2–3, >4 y after previous birth 35/30 Same as above As above 1.6 1.8 0.94–3.6 
Last of 2–3, <5 y after previous birth 48/53 Same as above As above 1.6 1.7 0.94–2.9 
Last of >3, >4 y after previous birth 11/15 Same as above As above 1.4 1.4 0.53–3.6 
Last of >3, <5 y after previous birth 29/29 Same as above As above 1.8 1.7 0.83–3.6 
Middle of 3, >4 y between sib births 2/6 Same as above As above 0.4 0.7 0.12–3.6 
Middle of 3, <5 y before next, >4 y after previous sib birth 4/5 Same as above As above 1.3 1.6 0.37–6.8 
Middle of 3, <5 y after previous, >4 y before next sib birth 15/10 Same as above As above 2.1 2.2 0.81–5.7 
Middle of 3, <5 y between sib births 12/15 Same as above As above 1.4 1.4 0.55–3.8 
Middle of 3, unknown birth order 17/36 Same as above As above 0.66 0.7 0.34–1.6 
Middle of >3, >4 y between births 6/4 Same as above As above 2.8 2.5 0.64–9.9 
Middle of >3, <5 y before next, >4 y after previous birth 13/17 Same as above As above 1.2 1.2 0.52–2.8 
Middle of >3, <5 y after previous, >4 yrs before next birth 18/19 Same as above As above 1.3 1.2 0.47–2.8 
Middle of >3, unknown birth order 17/31 Same as above As above 0.82 0.9 0.41–1.8 
>6, Unknown sib-ship structure 18/19 Same as above As above 1.7 1.9 0.87–4.1 
Unknown sib-ship size 45/46 Same as above As above 1.7 1.3 0.59–2.7 

Abbreviations: CA/CO, #cases/#controls; OR UNIV, univariate OR; OR ADJ, adjusted OR; ADJ CI, adjusted confidence interval.

aAdjusted for birth county humidity and median education, height, parental status, blood type, infectious mononucleosis, sexually transmitted infections, lymphadenitis, and childhood exanthemata/mumps.

Preservice geographic factors

Crude measures of higher risk for those born in a high 1950 Hodgkin lymphoma-mortality, urban, or affluent county, or in a county subject to high annual days below freezing, days over 90°, or hours of insolation, were not significant after adjustment for family configuration and other individual predictors, but a link with the mean birth county educational level remained conventionally significant after adjustment, as did an association with a single meteorological variable: the annual days of birth county high humidity (Table 3). When conscripts had moved between counties at different 1950 Hodgkin lymphoma mortality rates before induction, the direction of movement was mostly toward counties at higher apparent risk and the level of risk tracked significantly with birthplace rather than residence at induction. Neither season of birth nor season of diagnosis was related to risk (data not shown).

Table 3.

Impact of preinduction geographical origins

VariableCategoryCA/COReferentCA/COOR UNIVOR ADJaADJ CI
Birth county median family income in 1959 > $5787 315/259 <$4185 (OR, 1.0) 179/229 1.6 1.1 0.78–1.7 
Birth county median years education in 1959 >10 y 324/256 0–10 y (OR, 1.0) 330/392 1.5 1.4 1.1–1.8 
Birth county latitude >37.8° North 462/405 <37.9° N (OR, 1.0) 193/243 1.5 1.1 0.70–1.6 
Birth county mean annual humidity (pan evaporation) 0–48 inches 416/360 >48 inches (OR, 1.0) 234/277 1.4 1.4 1.1–1.8 
Preinduction migration to another county To next higher county risk quartileb 27/25 None (OR, 1.0) 554/537 0.8 0.7 0.38–1.2 
Preinduction migration to another county To two quartiles of county risk higherb 9/26 None (OR, 1.0) 554/537 0.4 0.5 0.20–1.0 
Residence at induction Urban 497/465 Rural (OR, 1.0) 159/190 1.3 1.2 0.83–1.6 
VariableCategoryCA/COReferentCA/COOR UNIVOR ADJaADJ CI
Birth county median family income in 1959 > $5787 315/259 <$4185 (OR, 1.0) 179/229 1.6 1.1 0.78–1.7 
Birth county median years education in 1959 >10 y 324/256 0–10 y (OR, 1.0) 330/392 1.5 1.4 1.1–1.8 
Birth county latitude >37.8° North 462/405 <37.9° N (OR, 1.0) 193/243 1.5 1.1 0.70–1.6 
Birth county mean annual humidity (pan evaporation) 0–48 inches 416/360 >48 inches (OR, 1.0) 234/277 1.4 1.4 1.1–1.8 
Preinduction migration to another county To next higher county risk quartileb 27/25 None (OR, 1.0) 554/537 0.8 0.7 0.38–1.2 
Preinduction migration to another county To two quartiles of county risk higherb 9/26 None (OR, 1.0) 554/537 0.4 0.5 0.20–1.0 
Residence at induction Urban 497/465 Rural (OR, 1.0) 159/190 1.3 1.2 0.83–1.6 

Abbreviations: CA/CO, #cases/#controls; OR UNIV, univariate OR; OR ADJ, adjusted OR; ADJ CI, adjusted confidence interval.

aExcluding factor of interest, adjusted for birth county humidity and median education, family configuration, height, parental status, blood type, infectious mononucleosis, sexually transmitted infections, lymphadenitis, and childhood exanthemata/mumps.

Test for trend.

bMigration to a higher-risk county; crude P = 0.02; adjusted P = 0.04.

Demographic factors

The mean age of cases was 19.8 years with an SD of 2.2 and a median age of 19.3 years. Inductees with Hispanic surnames, but not African Americans, tended to be at lower risk of subsequent AYAHL (Table 4). The few Jewish servicemen were at (nonsignificantly) higher risk, but no meaningful difference in risk was found between Catholics and Protestants, or between other ethnic subgroups (not shown). Greater height and weight [body mass index (BMI)] at induction were independently found at higher risk, in each case with a significant ordinal trend. The higher crude risk of those with higher rank, with more education, with a higher score from the “aptitude” test given at induction, or with a professional preinduction occupation (not shown) was reduced to near unity after adjustment for other variables. Although marital status was not related to risk, those who had become parents before induction were found to be at significantly higher risk, especially after adjustment.

Table 4.

Impact of demographic and personal characteristics

VariableCategoryCA/COReferent (OR, 1.0)CA/COUnivariate ORAdjusteda ORADJ CI
Ethnicity (from surname) Hispanic 6/24 English (OR, 1.0) 259/227 0.3 0.3 0.10–1.0 
Religion Jewish 14/7 Protestant (OR, 1.0) 413/439 2.0 1.7 0.56–5.1 
Race African American 53/49 White (OR, 1.0) 603/596 0.9 1.5 0.93–2.5 
Heightb 67–69 inches 202/188 <67 inches (OR, 1.0) 192/238 1.4 1.2 0.90–1.7 
Heightb 70+ inches 257/218 <67 inches (OR, 1.0) 107/153 1.5 1.5 1.1–2.1 
BMIc 20–24.9 243/261 <20 (OR, 1.0) 119/144 1.1 1.1 0.78–1.6 
BMIc 25+ 289/238 <20 (OR, 1.0) 119/144 1.5 1.5 1.0–2.1 
Years of education >11 388/340 0–10 (OR, 1.0) 267/307 1.4 1.0 0.67–1.4 
Induction test scored Quintile 2–3 447/404 Quintile 1 (OR, 1.0) 59/49 0.9 1.2 0.77–2.0 
Induction test scored Quintile 4–5 98/134 Quintile 1 (OR, 1.0) 59/49 0.5 0.8 0.45–1.4 
Rank Officer 48/40 Enlisted man (OR, 1.0) 608/614 1.3 1.0 0.54–1.8 
Preinduction marital status Yes 59/61 Single (OR, 1.0) 590–588 1.0 0.9 0.52–1.5 
Preinduction parental status Yes 62/37 No (OR, 1.0) 594/619 1.9 2.6 1.4–4.8 
VariableCategoryCA/COReferent (OR, 1.0)CA/COUnivariate ORAdjusteda ORADJ CI
Ethnicity (from surname) Hispanic 6/24 English (OR, 1.0) 259/227 0.3 0.3 0.10–1.0 
Religion Jewish 14/7 Protestant (OR, 1.0) 413/439 2.0 1.7 0.56–5.1 
Race African American 53/49 White (OR, 1.0) 603/596 0.9 1.5 0.93–2.5 
Heightb 67–69 inches 202/188 <67 inches (OR, 1.0) 192/238 1.4 1.2 0.90–1.7 
Heightb 70+ inches 257/218 <67 inches (OR, 1.0) 107/153 1.5 1.5 1.1–2.1 
BMIc 20–24.9 243/261 <20 (OR, 1.0) 119/144 1.1 1.1 0.78–1.6 
BMIc 25+ 289/238 <20 (OR, 1.0) 119/144 1.5 1.5 1.0–2.1 
Years of education >11 388/340 0–10 (OR, 1.0) 267/307 1.4 1.0 0.67–1.4 
Induction test scored Quintile 2–3 447/404 Quintile 1 (OR, 1.0) 59/49 0.9 1.2 0.77–2.0 
Induction test scored Quintile 4–5 98/134 Quintile 1 (OR, 1.0) 59/49 0.5 0.8 0.45–1.4 
Rank Officer 48/40 Enlisted man (OR, 1.0) 608/614 1.3 1.0 0.54–1.8 
Preinduction marital status Yes 59/61 Single (OR, 1.0) 590–588 1.0 0.9 0.52–1.5 
Preinduction parental status Yes 62/37 No (OR, 1.0) 594/619 1.9 2.6 1.4–4.8 

Abbreviations: CA/CO, #cases/#controls; ADJ CI, adjusted CI.

aExcluding factor of interest, adjusted for birth county humidity and median education, family configuration, height, parental status, blood type, infectious mononucleosis, sexually transmitted infections, lymphadenitis, and childhood exanthemata/mumps.

b-dTests for trend:

bHeight: crude P = 0.02; adjusted P = 0.05.

cBMI: crude P = 0.01; adjusted P = 0.03.

dInduction test score: crude P = 0.04; adjusted P = 0.07.

Medical and service-related factors

Carriers of blood group B, with or without A, were at significantly increased risk. A history of childhood transmissible infection (exanthemata, mumps) was significantly linked to lower risk, as was a past sexually transmitted infection (STD; Table 5). Preinduction infectious mononucleosis was positively and significantly associated with future AYAHL. Past asthma was nonsignificantly predictive of diagnosis, although neither hay fever, unspecified allergy, nor a family history of asthma (or of unspecified cancer) was associated with disease. Nonsignificant positive associations were found for prior appendectomy and especially tonsillectomy/tonsillitis. No service history factor (combat, medical, radar, food service) was associated with risk (not shown).

Table 5.

Impact of medical and service history

VariableCategoryCA/COReferentCA/COOR UNIVOR ADJaADJ CI
Blood type B/AB 93/60 O/A (OR, 1.0) 505/535 1.8 1.7 1.1–2.5 
Asthma Yes 13/5 No (OR, 1.0) 600/584 2.4 2.0 0.64–6.5 
Hay fever Yes 34/27 No (OR, 1.0) 572/263 1.2 1.1 0.62–2.1 
Allergy Yes 42/39 No (OR, 1.0) 650/648 1.1 1.0 0.59–1.8 
Tonsillectomy Yes 470/498 No (OR, 1.0) 470/498 1.6 1.3 0.88–1.8 
Appendectomy Yes 78/70 No (OR, 1.0) 531/521 1.1 1.2 0.76–1.8 
Sexually transmitted infection Yes 53/72 No (OR, 1.0) 603/584 0.7 0.6 0.39–0.97 
Childhood exanthemata/mumps Yes 8/26 No (OR, 1.0) 652/640 0.3 0.2 0.08–0.48 
Infectious mononucleosis Yes 16/4 No (OR, 1.0) 640/652 4.0 5.6 1.7–19 
VariableCategoryCA/COReferentCA/COOR UNIVOR ADJaADJ CI
Blood type B/AB 93/60 O/A (OR, 1.0) 505/535 1.8 1.7 1.1–2.5 
Asthma Yes 13/5 No (OR, 1.0) 600/584 2.4 2.0 0.64–6.5 
Hay fever Yes 34/27 No (OR, 1.0) 572/263 1.2 1.1 0.62–2.1 
Allergy Yes 42/39 No (OR, 1.0) 650/648 1.1 1.0 0.59–1.8 
Tonsillectomy Yes 470/498 No (OR, 1.0) 470/498 1.6 1.3 0.88–1.8 
Appendectomy Yes 78/70 No (OR, 1.0) 531/521 1.1 1.2 0.76–1.8 
Sexually transmitted infection Yes 53/72 No (OR, 1.0) 603/584 0.7 0.6 0.39–0.97 
Childhood exanthemata/mumps Yes 8/26 No (OR, 1.0) 652/640 0.3 0.2 0.08–0.48 
Infectious mononucleosis Yes 16/4 No (OR, 1.0) 640/652 4.0 5.6 1.7–19 

Abbreviations: CA/CO, #cases/#controls; OR UNIV, univariate odds ratio; OR ADJ, adjusted odds ratio; ADJ CI, adjusted confidence interval.

aExcluding factor of interest, adjusted for birth county humidity and median education, family configuration, height, parental status, blood type, infectious mononucleosis, sexually transmitted infections, lymphadenitis, and childhood exanthemata/mumps.

Risk modification by family configuration

Each adult characteristic was examined according to three empirically defined strata of risk based on the sib-ship (childhood) configuration (Table 6). Associations between Hodgkin lymphoma and infectious mononucleosis, blood group, BMI, tonsillectomy, height, parental status and childhood infection all became more extreme after this adjustment.

Table 6.

Risk modification by risk stratum of sibling configuration

Low-risk sibling configuration 94/287: OR ≤ 1.5Medium-risk sibling configuration 192/194: OR = 1.5–1.99High-risk sibling configuration 267/175: OR = 2.0+
ComparisonCA/COORCICA/COORCICA/COORCI
Height 
 69+ vs. <67 in (OR, 1.0) 69/82 1.1 0.51–2.2 64/70 0.8 0.34–1.7 124/66 1.7 0.73–3.8 
BMI 
 25+ vs. <20 (OR, 1.0) 80/87 2.0 0.89–4.4 79/71 2.0 0.76–5.4 130/80 1.1 0.44–2.8 
Parenthood 
 Yes vs. no (OR, 1.0) 36/29 2.4 1.0–5.9 12/3 4.2a 1.2–15a 14/5 2.0 0.3–11 
Blood type 
 B-AB vs. O/A (OR, 1.0) 30/28 3.0 1.1–8.3 30/14 1.5 0.42–5.3 33/18 1.8 0.51–6.0 
Tonsillectomy 
 Yes vs. no (OR, 1.0) 29/27 1.5 0.53–4.2 42/27 1.2 0.51–3.0 71/44 1.2 0.53–2.6 
Childhood exanthema/mumps 
 Yes vs. no (OR, 1.0) 4/9 0.4 0.08–2.1 1/10 0.1a 0.03–0.56a 3/7 1.0 0.06–16 
Infectious mononucleosis 
 Yes vs. no (OR, 1.0) 2/2 1.5a 0.20–11.0a 7/0 ∼ — 7/2 3.0 0.31–29 
Low-risk sibling configuration 94/287: OR ≤ 1.5Medium-risk sibling configuration 192/194: OR = 1.5–1.99High-risk sibling configuration 267/175: OR = 2.0+
ComparisonCA/COORCICA/COORCICA/COORCI
Height 
 69+ vs. <67 in (OR, 1.0) 69/82 1.1 0.51–2.2 64/70 0.8 0.34–1.7 124/66 1.7 0.73–3.8 
BMI 
 25+ vs. <20 (OR, 1.0) 80/87 2.0 0.89–4.4 79/71 2.0 0.76–5.4 130/80 1.1 0.44–2.8 
Parenthood 
 Yes vs. no (OR, 1.0) 36/29 2.4 1.0–5.9 12/3 4.2a 1.2–15a 14/5 2.0 0.3–11 
Blood type 
 B-AB vs. O/A (OR, 1.0) 30/28 3.0 1.1–8.3 30/14 1.5 0.42–5.3 33/18 1.8 0.51–6.0 
Tonsillectomy 
 Yes vs. no (OR, 1.0) 29/27 1.5 0.53–4.2 42/27 1.2 0.51–3.0 71/44 1.2 0.53–2.6 
Childhood exanthema/mumps 
 Yes vs. no (OR, 1.0) 4/9 0.4 0.08–2.1 1/10 0.1a 0.03–0.56a 3/7 1.0 0.06–16 
Infectious mononucleosis 
 Yes vs. no (OR, 1.0) 2/2 1.5a 0.20–11.0a 7/0 ∼ — 7/2 3.0 0.31–29 

Abbreviation: CA/CO, #cases/#controls.

aEstimated after breaking the pairwise matching.

Risk modification by histologic type

Of the 501 tumor specimens examined, 50.0% were of nodular sclerosis, 33.5% of mixed cellularity, and 16.5% of the less frequent histiotypes (Table 7). No meaningful differences distinguished risk factors for nodular sclerosis from those for mixed cellularity.

Table 7.

Risk modification by histologic type

Nodular sclerosis (249)Mixed cell (168)Other known (84)
CA/COORCICA/COORCICA/COORCI
Sibling configurationa 
 1.5–1.99 vs. <1.5 in (referent) 44/48 1.1 0.61–2.02 34/29 1.6 0.79–3.03 21/14 2.0 0.72–5.44 
Sibling configurationa 
 2.0+ vs. <1.5 (referent) 61/46 1.6 0.94–2.81 39/34 1.6 0.79–3.12 17/20 1.2 0.47–2.95 
Height 
 66+ vs. <66 inches (referent) 130/119 1.5 0.80–2.94 91/77 2.1 1.05–4.15 42/42 0.9 0.32–2.41 
BMI 
 25+ vs. <20 (referent) 65/58 1.4 0.74–2.6 52/36 1.8 0.85–4.0 25/20 1.9 0.63–5.4 
Parenthood 
 Yes vs. no (referent) 14/8 2.2 0.76–6.33 11/3 5.0 1.10–22.8 4/4 1.0 0.25–4.00 
Blood type 
 B-AB vs. O/A in (referent) 14/15 1.2 0.53–2.64 18/7 4.7 1.34–16.2 11/7 1.5 0.42–5.32 
Infectious mononucleosis 
 Yes vs. no (referent) 1/2 0.5 0.05–5.5 3/2 1.5 0.30–9.0 1/0 — — 
Tonsillectomy 
 Yes vs. no in (referent) 31/20 1.9 0.95–3.85 29/16 1.9 0.95–3.85 8/13 0.8 0.26–2.16 
Nodular sclerosis (249)Mixed cell (168)Other known (84)
CA/COORCICA/COORCICA/COORCI
Sibling configurationa 
 1.5–1.99 vs. <1.5 in (referent) 44/48 1.1 0.61–2.02 34/29 1.6 0.79–3.03 21/14 2.0 0.72–5.44 
Sibling configurationa 
 2.0+ vs. <1.5 (referent) 61/46 1.6 0.94–2.81 39/34 1.6 0.79–3.12 17/20 1.2 0.47–2.95 
Height 
 66+ vs. <66 inches (referent) 130/119 1.5 0.80–2.94 91/77 2.1 1.05–4.15 42/42 0.9 0.32–2.41 
BMI 
 25+ vs. <20 (referent) 65/58 1.4 0.74–2.6 52/36 1.8 0.85–4.0 25/20 1.9 0.63–5.4 
Parenthood 
 Yes vs. no (referent) 14/8 2.2 0.76–6.33 11/3 5.0 1.10–22.8 4/4 1.0 0.25–4.00 
Blood type 
 B-AB vs. O/A in (referent) 14/15 1.2 0.53–2.64 18/7 4.7 1.34–16.2 11/7 1.5 0.42–5.32 
Infectious mononucleosis 
 Yes vs. no (referent) 1/2 0.5 0.05–5.5 3/2 1.5 0.30–9.0 1/0 — — 
Tonsillectomy 
 Yes vs. no in (referent) 31/20 1.9 0.95–3.85 29/16 1.9 0.95–3.85 8/13 0.8 0.26–2.16 

Abbreviation: CA/CO, #cases/#controls.

aCategorical OR.

Abstraction of records for this study began in 1972 and was completed within 2 years; no previous publications have appeared. Many of the individual findings have been previously reported by smaller and/or less well controlled investigations. Belated publication is warranted not only because of a few provocative novel findings, but also because the sample is large, the findings are detailed and extraordinarily free from bias, and the results can be applied with virtually no restriction to previously healthy U.S. males ages 17 to 32 years.

More frequent diagnoses of AYAHL have repeatedly been found among those of higher social class, as measured by education, income, or occupation, and that fact is consistent on a population basis with an increase in risk accompanying economic development. One important question to address is whether that link represents a causal event in the post-pubertal or adult years just before diagnosis, or, because adult social class is largely determined by parental education and affluence, whether the causal roots go back to early life. Some determinants do not distinguish between the alternatives. Adult increases in height and BMI, common factors cited in previous studies (43–51), can be tracked back to the nutritional and clinical benefits of childhood affluence (52). Information obtained at diagnosis may be colored by the moment and analytic studies often have insufficient power to distinguish between the two periods, even if specific childhood circumstances are known. Here, the availability of information is unrelated to either education or retrospective perception, and is free of selection or information bias.

Adjustment for the childhood environment and medical history eliminated the commonly reported risk indicators of higher adult social class, including occupation, service rank, “aptitude” induction test score, marriage, or service assignment. Although previous investigators (53, 54) found a higher risk not only among Jewish servicemen, but also among officers and those with higher induction test scores or professional preservice occupations, no adjustments for childhood characteristics were made. Adult smoking, a surrogate for lower levels of adulthood education, has been linked to all Hodgkin lymphoma, but not consistently to AYAHL (55–59).

In contrast, after adjustment for other determinants, the number, order, and proximity of sibs still differed dramatically between cases and controls (60–63), and those differences are unlikely to have more than negligible bearing on the adult life experience.

The next task is to identify the nature of the pertinent childhood exposure, and the first consideration is the particular age at which that occurs. The sib-ship differences are unlikely to be a consequence of gestational events, which have been hypothesized to play a causal role (64), but it could reflect exposures at either preschool ages or later. As infants and toddlers, children first explore the world. Affluent parents are likely to be more protective of only children, or children without siblings near in age, and less protective of individual children in large sib-ships. In a study of twins discordant for AYAHL, we found that the twin who reported, and was reported to have, more early oral exposures was five times more likely to be the affected twin (65).

Sib-ship patterns are sure to influence childhood exposures in other ways. Person-to-person infections pass between siblings, and between classmates, and the greater the number of closely spaced siblings, the more infectious agents are passed on. The prevalence of infection with Helicobacter pylori in adulthood, for example, is strongly correlated with sib-ship size (66, 67). Moreover, even after adjustment for their sib-ship configuration, these cases reported fewer childhood viral infections (and fewer sexually transmitted infections) than did controls (68–70). They also had experienced more frequently reported past infectious mononucleosis (71–78), a separate indication of comparatively infrequent interpersonal childhood exposure. [Hjalgrim and colleagues (12) observed fewer serologic reports of IM among EBV-negative Hodgkin lymphoma cases than expected, a finding seemingly inconsistent with the fourfold increase in risk found here, but his cases of comparable age were still much more likely than expected to have had recent IM within an interval that would have included the preinduction teenage years of these servicemen.]

In contrast with the inverse association between childhood infection and AYAHL, another marker of childhood infection, tonsillectomy, which usually occurs at a later age, has repeatedly been found to be associated with risk (37, 60, 79–85), although often without appropriate adjustment for other determinants. While it actually may act as a measure of better access to care (a surrogate for high social class), it has also been found associated with AYAHL in a study of disease-discordant twins (65), uniquely matched on genome, childhood environment, and presumably access to care. Here, we also found a positive (albeit nonsignificant) association with that operation as well as with appendectomy.

For better or worse, advantaged children are deprived at all ages of much of the lifetime protection that follows early infection with specific immunogenic agents, and are also deprived of the early infections and exposures that produce lifetime immune competence. Thus an advantaged childhood as a risk indicator does not serve to exclude either of the hypotheses that could explain the link to economic development/higher socioeconomic status. Although we could not add to the evidence suggesting that diagnosis follows a deficiency of early acquired immunity (7, 65), the major finding of a protected family environment certainly supports that hypothesis.

In contrast with Hodgkin lymphoma at older ages, EBV is unlikely to play a causal role in most cases of AYAHD (86). We found no seasonal mal-distribution of either date of birth or of diagnosis as have some previous investigators (87–90), and although medical workers have (inconsistently) been found at higher risk of Hodgkin lymphoma (91, 92), we found no such suggestion. Causation by a ubiquitous immunogenic virus is not ruled out by such negative findings, and despite the failure to date to identify a promising candidate agent (93), several of our findings do indirectly suggest that possibility. Continued incremental reduction in risk in the presence of higher sib-ship size and a reduction in association with wider spacing of siblings are two observations consistent with personal protection by virtue of early exposure to infected siblings. More suggestive is the higher risk among those who had become parents but not after marriage alone, possibly because the latter does not greatly alter the microbial environment. Others have found prediagnosis infections (other than infectious mononucleosis) to be more prominent among cases (94), and it is tempting to interpret parentage as a measure of exposure to an ubiquitous but unrecognized virus of childhood.

One other observation is weakly suggestive of an infectious agent. A significant increase in risk was attendant upon those who carry the B or AB genotypes of the ABO system. ABO antigens are present on a wide variety of cells, especially those of the gastrointestinal mucosa, and provide receptors for gastrointestinal infections (rotavirus, norovirus; ref. 95), they also have been linked to bacterial throat carriage (96), and B group antigen specifically is known to modulate the composition of the intestinal microbiota (97).

Within this very restricted age group, no etiologic differences between nodular sclerosis and mixed cell Hodgkin lymphoma were found, and other histologic subtypes were infrequent. While the cases were diagnosed before recognition of intra-HRS cell EBV, the proportion of EBV-positive cases among those diagnosed in the United States around age 20 is likely to have been no more than about 25% (98).

In summary, we have provided strong evidence that the genesis of AYAHL occurs in childhood, some additional evidence supporting causation of a ubiquitous childhood virus, and findings compatible with causation by virtue of an insufficiently developed acquired immunity. The strengths of this study are the large sample size, the demographic and clinical uniformity of cases, the wealth of information, the population-based source and the nested case–control design, which together have largely eliminated both selection and information bias. The liabilities include restriction to male cases, the absence of EBV antigen characterization, and the reliance on behavioral descriptors of a past era that may no longer have the same significance. Little girls behave differently than little boys, restricting the interpretation, and the dynamics of social contact have certainly changed, restricting the feasibility of replication, but not the interpretation.

No potential conflicts of interest were disclosed.

Conception and design: T.M. Mack

Development of methodology: T.M. Mack

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): J.E. Norman

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): T.M. Mack, J.E. Norman, E. Rappaport, W. Cozen

Writing, review, and/or revision of the manuscript: T.M. Mack, J.E. Norman, W. Cozen

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): T.M. Mack, J.E. Norman

Study supervision: T.M. Mack

The authors thank Joseph P. Fraumeni Jr of the NCI for support and encouragement, the late Gilbert W. Beebe, then of the Clinical Epidemiology Branch, Division of Cancer Etiology, NCI, who advised on the study design and execution from the outset, and the late Francis M. King of the Armed Forces Institute of Pathology, a co-investigator with the appropriate expertise in Pathology. They also thank the staff of the Follow-up Agency of the National Research Council for their efforts in completing this complex and difficult investigation.

This work was supported by a contract to T.M. Mack from the Epidemiology Branch, National Cancer Institute, NIH. T.M. Mack is currently supported by 1U58DP000807-05 (CA Department of Public Health) and CA5R01CA165038-02 (NIH). W. Cozen is currently supported by 1R01CA58839, R03CA110836-01A2, and 1R03CA110836-01A2 (NCI) and 6137-07 (Leukemia & Lymphoma Society).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1.
MacMahon
B
. 
Epidemiological evidence on the nature of Hodgkin's disease
.
Cancer
1957
;
10
:
1045
54
.
2.
Correa
P
,
O'Conor
GT
. 
Epidemiologic patterns of Hodgkin's disease
.
Int J Cancer
1971
;
8
:
192
201
.
3.
MacFarlane
GJ
,
Evstifeeva
T
,
Boyle
P
,
Grufferman
S
. 
International patterns in the occurrence of Hodgkin's disease in children and young adult males
.
Int J Cancer
1995
;
61
:
165
9
.
4.
Cozen
W
,
Gill
P
,
Salam
M
,
Nieters
A
,
Masood
R
,
Cockburn
M
, et al
Interleukin-2, interleukin-12 and interferon-γ levels and risk of young adult Hodgkin lymphoma
.
Blood
2008
;
111
:
3377
82
.
5.
Eberle
F
,
Mani
H
,
Jaffe
E
. 
Histopathology of Hodgkin's lymphoma
.
Cancer J
2009
;
15
:
129
37
.
6.
Lukes
RJ
,
Craver
LF
,
Hall
TC
,
Rappaport
H
,
Rubin
P
. 
Report of the nomenclature committee
.
Cancer Res
1966
;
26
:
1311
.
7.
Cozen
W
,
Yu
G
,
Gail
M
,
Mack
T
,
Ridaura
V
,
Nathwani
B
, et al
Fecal microbiome diversity and risk of adolescent/young adult Hodgkin lymphoma
.
Br J CA
2013
;
108
:
1163
7
.
8.
Group AaYAOPR
. 
Closing the gap: research and care imperatives for adolescents and young adults with cancer
.
Washington, DC
:
National Cancer Institute
; 
2006
.
9.
Harris
N
,
Jaffe
E
,
Stein
H
,
Banks
P
,
Chan
J
,
Cleary
M
, et al
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group
.
Blood
1994
;
84
:
1361
92
.
10.
Piler
S
,
Ascani
S
,
Leoncini
L
,
Sabattini
E
,
Zinzani
P
,
Piccaluga
P
, et al
Hodgkin's lymphoma: the pathologist's viewpoint
.
J Clin Path
2012
;
55
:
162
76
.
11.
Weiss
L
,
Chen
Y
,
Liu
X
,
Shibata
D
. 
Epstein–Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study
.
Am J Pathol
1991
;
139
:
1259
65
.
12.
Hjalgrim
H
,
Smedby
K
,
Rostgaard
K
,
Molin
D
,
Hamilton-Dutoit
S
,
Chang
E
, et al
Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma
.
Cancer Res
2007
;
67
:
2382
8
.
13.
Levin
L
,
Chang
E
,
Ambinder
RF
,
Lennette
ET
,
Rubertone
M
,
Marin
R
, et al
Atypical Epstein–Barr virus serology restricted to EBV-positive Hodgkin lymphoma
.
Blood
2012
;
120
:
3750
5
.
14.
Sleckman
B
,
Mauch
P
,
Ambinder
RF
,
Mann
R
,
Pinkus
G
,
Kadin
ME
, et al
Epstein–Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection
.
Cancer Res
1998
;
34
:
1156
60
.
15.
Huang
X
,
Nolte
I
,
Gao
Z
,
Vos
H
,
Hepkema
B
,
Poppema
S
, et al
Epidemiology of classical Hodgkin lymphoma and its association with Epstein–Barr virus in Northern China
.
PLoS ONE
2011
;
6
.
16.
Goldin
L
,
Pfeiffer
R
,
Gridley
G
,
Gail
M
,
Li
X
,
Mellemkjaer
L
, et al
Familial aggregation of Hodgkin lymphoma and related tumors
.
Cancer
2004
;
100
:
1902
8
.
17.
Grufferman
S
,
Cole
P
,
Smith
PG
,
Lukes
RJ
. 
Hodgkin's disease in siblings
.
N Engl J Med
1977
;
296
:
248
50
.
18.
Crump
C
,
Sunquist
K
,
Sieh
W
,
Winkleby
M
,
Sundquist
J
. 
Perinatal and family risk factors for Hodgkin lymphoma in childood through young adulthood
.
Am J Epidemiol
2012
;
176
:
1147
58
.
19.
Mack
T
,
Cozen
W
,
Shibata
D
,
Weiss
L
,
Nathwani
B
,
Hernandez
A
, et al
Concordance for Hodgkin's disease in identical twins suggests genetic susceptibility to the young-adult form of the disease
.
N Eng J Med
1995
;
332
:
413
8
.
20.
Cozen
W
,
Li
D
,
Best
T
,
Van Den Berg
D
,
Gourraud
P-A
,
Cortessis
V
, et al
A meta-analysis of nodular sclerosis Hodgkin lymphoma identifies risk loci at 6p21.32
.
Blood
2012
;
119
:
469
75
.
21.
Cozen
W
,
Gill
P
,
Ingles
S
,
Masood
R
,
Martinez-Maza
O
,
Cockburn
M
, et al
IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma
.
Blood
2004
;
103
:
3216
21
.
22.
Martinez-Maza
O
,
Moreno
A
,
Cozen
W
. 
Epidemiological evidence: IgE, allergies and hematopoietic malignancies
. In:
Penichet
M
,
Jensen-Jarolim
E
, editors. 
Cancer and IgE: introducing the concept of AllergoOncology
.
New York, NY
:
Springer Science
; 
2009
23.
Shugart
YY
,
Hemminki
K
,
Vaittinen
P
,
Kingman
A
,
Dong
C
. 
A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden
.
Hum Genet
2000
;
106
:
553
6
.
24.
Cozen
W
,
Katz
J
,
Mack
TM
. 
Risk patterns of Hodgkin's disease in Los Angeles vary by cell type
.
Cancer Epidemiol Biomarkers Prev
1992
;
1
:
261
8
.
25.
Hjalgrim
H
,
Askling
J
,
Pukkela
E
,
Hansen
S
,
Munksgaard
L
,
Frisch
M
. 
Incidence of Hodgkin's disease in Nordic countries
.
Lancet
2001
;
358
:
297
8
.
26.
Aben
K
,
van Gaal
C
,
van Gils
N
,
van der Graaf
W
,
Zielhuis
G
. 
Cancer in adolescents and young adults (15–29 years): a population-based study in the Netherlands 1989–2009
.
Acta Oncologica
2012
;
51
:
922
33
.
27.
Hjalgrim
H
,
Seow
A
,
Rostgaard
K
,
Friborg
J
. 
Changing patterns of Hodgkin lymphoma incidence in Singapore
.
Int J Cancer
2008
;
123
:
716
9
.
28.
Koh
Y
,
Kang
H
,
Yoon
D
,
Suh
C
,
Kim
J
,
Kim
C
, et al
Changing trend of Epstein–Barr virus association in Hodgkin lymphoma in the Republic of Korea
.
Ann Hematol
2013
;
92
:
1653
60
.
29.
Chihara
D
,
Ito
H
,
Matsuda
T
,
Shibata
A
,
Katsumi
A
,
Nakamura
S
, et al
Differences in incidence and trends of haematological malignancies in Japan and the United States
.
Br J Haematol
2014
;
164
:
536
45
.
30.
Clarke
C
,
Glaser
S
,
Keegan
T
,
Stroup
A
. 
Neighborhood Socioeconomic status and Hodgkin's lymphoma incidence in California
.
Cancer Epidemiol Biomark Prev
2005
;
14
:
1441
7
.
31.
Jarrett
R
. 
Viruses and leukemia/lymphoma
.
J Pathol
2006
;
208
:
176
86
.
32.
Cole
P
. 
Epidemiology of Hodgkin's disease
.
Jama
1972
;
222
:
1636
9
.
33.
Aisenberg
AC
. 
Hodgkin's disease—prognosis, treatment and etiologic and immunologic considerations (concluded)
.
N Eng J Med
1964
;
270
:
617
22
.
34.
Gutensohn
N
,
Cole
P
. 
Epidemiology of Hodgkin's disease in the young
.
Int J Cancer
1977
;
19
:
595
604
.
35.
Crawford
D
. 
Biology and disease associations of Epstein–Barr virus
.
Philos Trans R Soc Lond B Biol Sci
2001
;
356
:
461
73
.
36.
Monnereau
A
,
Glaser
SL
,
Schupp
C
,
Ekström-Smedby
K
,
de Sanjose
S
,
Kane
E
, et al
Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis
.
Blood
2013
;
122
:
3492
9
.
37.
Henderson
BE
,
Dworsky
R
,
Pike
MC
,
Baptista
J
,
Menck
H
,
Preston-Martin
S
, et al
Risk factors for nodular sclerosis and other types of Hodgkin's disease
.
Cancer Res
1979
;
39
:
4507
11
.
38.
Serraino
D
,
Franceschi
S
,
Talamini
R
,
Barra
S
,
Negri
E
,
Carbone
A
, et al
Socio-economic indicators, infectious diseases and Hodgkin's disease
.
Int J Cancer
1991
;
47
:
352
7
.
39.
Page
W
,
Mack
T
,
Kurtzke
J
,
Norman
J
. 
Epidemiology of multiple sclerosis in US Veterans: VI. Population ancestry and surname ethnicity as risk factors for MS
.
Neuroepidemiology
1995
;
14
:
286
96
.
40.
Anonymous
. 
U.S. 1960 decennial census
.
Washington, DC
:
Census Bureau, Department of Commerce
; 
1960
.
41.
Cole
P
,
MacMahon
B
. 
Mortality from Hodgkin's disease in the United States: evidence for the multiple-aetiology hypothesis
.
Lancet
1968
;
2
:
1371
6
.
42.
Lukes
RJ
,
Butler
JJ
. 
The pathology and nomenclature of Hodgkin's disease
.
Cancer Res
1966
;
26
:
1063
83
.
43.
Isager
H
,
Andersen
E
. 
Pre-morbid factors in Hodgkin's disease. I. Birth weight and growth pattern from 8 to 14 years of age
.
Scand J Haematol
1978
;
21
:
250
5
.
44.
Willett
E
,
Roman
E
. 
Obesity and the risk of Hodgkin's lymphoma
.
Cancer Causes Control
2006
;
17
:
1103
6
.
45.
Chang
E
,
Hjalgrim
H
,
Ekström-Smedby
K
,
Akerman
M
,
Tani
E
,
Johnson
H
, et al
Body mass index and risk of malignant lymphomas in Scandinavian men and women
.
J Nat Cancer Inst
2005
;
97
:
210
8
.
46.
Keegan
T
,
Glaser
SL
,
Clarke
C
,
Dorfman
R
,
Mann
R
,
DiGiuseppe
J
, et al
Body size physical activity, and risk of Hodgkin's lymphoma in women
.
Cancer Epidemiol Biomark Prev
2006
;
15
:
1095
201
.
47.
Fernberg
P
,
Odenbro
A
,
Bellocco
R
,
Boffetta
P
,
Pawitan
Y
,
Adami
HO
. 
Tobacco use, body mass index and the risk of malignant lymphomas—a nationwide cohort study in Sweden
.
Int J Cancer
2006
;
118
:
2298
302
.
48.
Lim
U
,
Morton
L
,
Subar
A
,
Baris
D
,
Stolzenberg-Solomon
R
,
Leitzmann
M
, et al
Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk
.
Am J Epidemiol
2007
;
166
:
697
708
.
49.
Larsson
S
,
Wolk
A
. 
Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies (review)
.
Eur J Cancer
2011
;
47
:
2422
30
.
50.
Li
Q
,
Chang
E
,
Bassig
B
,
Dai
M
,
Qin
Q
,
Gao
Y
, et al
Body size and risk of Hodgkin's lymphoma by age and gender: a population-based case–control study in Connecticut and Massachusetts
.
Cancer Causes & Control
2013
;
24
:
287
95
.
51.
Murphy
F
,
Kroll
M
,
Pirie
K
,
Reeves
G
,
Green
J
,
Beral
V
. 
Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study
.
Br J Cancer
2013
;
108
:
2390
8
.
52.
Ulijaszek
S
. 
The international growth standard for children and adolescents project:environmental influences on preadolescent and adolescent growth in weight and height
.
Food Nutr Bull
2006
;
27
:
S279
94
.
53.
LeShan
L
,
Marvin
S
,
Lyerly
O
. 
Some evidence of a relationship between Hodgkin's disease and intelligence
.
AMA Arch Gen Psych
1959
;
1
:
45
7
.
54.
Cohen
B
,
Smetena
H
,
Miller
R
. 
Hodgkin's disease; long survival in in a study of 388 World War II army cases
.
Cancer
1964
;
17
:
856
66
.
55.
Briggs
N
,
Hall
H
,
Brann
E
,
Moriarty
C
,
Levine
R
. 
Cigarette smoking and risk of Hodgkin's disease: a population-based case–control study
.
Am J Epidemiol
2002
;
156
:
1011
20
.
56.
Besson
H
,
Brennan
P
,
Becker
N
,
de Sanjose
S
,
Nieters
A
,
Font
R
, et al
Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case–control study (EPILYMPH)
.
Br J Cancer
2006
;
95
:
378
84
.
57.
Hjalgrim
H
,
Ekström-Smedby
K
,
Rostgaard
K
,
Amini
R
,
Molin
D
,
Hamilton-Dutoit
S
, et al
Cigarette smoking and risk of Hodgkin lymphoma: a population-based case–control study
.
Cancer Epidemiol Biomarkers Preven
2007
;
16
:
1561
6
.
58.
Sergentanis
T
,
Kanavidis
P
,
Michelakos
T
,
Petridou
E
. 
Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease
.
Eur J Cancer
2013
;
22
:
131
50
.
59.
Kamper-Jorgensen
M
,
Rostgaard
K
,
Glaser
SL
,
Zahm
SH
,
Cozen
W
,
Smedby
K
, et al
Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (Interlymph)
.
Ann Oncol
2013
;
24
:
2245
55
.
60.
Gutensohn (Mueller)
N
,
Frederick
S
,
Li
P
,
Johnson
R
,
Cole
P
. 
Hodgkin's disease, tonsillectomy and family size
.
N Eng J Med
1975
;
292
:
22
5
.
61.
Westergaard
T
,
Melbye
M
,
Pedersen
J
,
Frisch
M
,
Olsen
J
,
Anderson
P
. 
Birth order, sibship size and risk of Hodgkin's disease in children and young adults: A population-based study of 31 million person-years
.
Int J Cancer
1977
;
72
:
977
81
.
62.
Altieri
A
,
Castro
F
,
Bermejo
J
,
Hemminki
K
. 
Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology
.
Cancer Epidemiol Biomarkers Prev
2006
;
15
:
1281
6
.
63.
Chang
E
,
Montgomery
S
,
Richiardi
L
,
Ehlin
A
,
Ekbom
A
,
Lambe
M
. 
Number of siblings and risk of Hodgkin's lymphoma
.
Cancer Epidemiol Biomarkers Prev
2004
;
13
:
1236
43
.
64.
Barker
D
,
Osmond
C
,
Thornburg
K
,
Kajantie
E
,
Ericsson
J
. 
The intrauterine origins of Hodgkin's lymphoma
.
Cancer Epidemiol Biomarkers Prev
2013
;
37
:
321
3
.
65.
Cozen
W
,
Hamilton
A
,
Zhao
P
,
Salam
M
,
Deapen
D
,
Nathwani
B
, et al
A protective role for early childhood exposures and young adult Hodgkin lymphoma
.
Bloos
2009
;
114
:
4014
20
.
66.
Blaser
M
,
Nomura
A
,
Lee
J
,
Stemmerman
G
,
Perez-Perez
G
. 
Early-life family structure and microbially induced cancer risk
.
PLoS Med
2007
;
4
:
e7
.
67.
Gao
L
,
Weck
M
,
Raum
E
,
Stegmaier
C
,
Rothenbacher
D
,
Brenner
H
. 
Sibship size, Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany
.
Int J Epidemiol
2010
;
39
:
129
34
.
68.
Gutensohn (Mueller)
N
,
Cole
P
. 
Childhood social environment and Hodgkin's disease
.
N Eng J Med
1981
;
304
:
135
40
.
69.
Paffenbarger
RS
 Jr
,
Wing
AL
,
Hyde
RT
. 
Characteristics in youth indicative of adult-onset Hodgkin's disease
.
J Natl Cancer Inst
1977
;
58
:
1489
91
.
70.
Alexander
FE
,
Jarrett
RF
,
Lawrence
D
,
Armstrong
AA
,
Freeland
J
,
Gokhale
DA
, et al
Risk factors for Hodgkin's disease by Epstein–Barr virus (EBV) status: prior infection by EBV and other agents
.
Br J Cancer
2000
;
82
:
1117
21
.
71.
Miller
R
,
Beebe
G
. 
Infectious mononucleosis and the empirical risk of cancer
.
J Nat Cancer Inst
1973
;
50
:
315
21
.
72.
Rosdahl
N
,
Larsen
SO
,
Clemmesen
J
. 
Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience
.
BMJ
1974
;
2
:
253
6
.
73.
Kvale
G
,
Hoiby
EA
,
Pedersen
E
. 
Hodgkin's disease in patients with previous infectious mononucleosis
.
Int J Cancer
1979
;
23
:
593
7
.
74.
Connelly
RR
,
Christine
BW
. 
A cohort study of cancer following infectious mononucleosis
.
Cancer Res
1974
;
34
:
1172
8
.
75.
Carter
CD
,
Brown
TM
,
Herbert
JT
,
Heath
CW
 Jr
. 
Cancer incidence following infectious mononucleosis
.
Am J Epidemiol
1977
;
105
:
30
6
.
76.
Munoz
N
,
Davidson
RJ
,
Witthoff
B
,
Ericsson
JE
,
De-The
G
. 
Infectious mononucleosis and Hodgkin's disease
.
Int J Cancer
1978
;
22
:
10
3
.
77.
Hjalgrim
H
,
Askling
J
,
Sorenson
P
,
Madsen
M
,
Rosdahl
N
,
Storm
H
, et al
Risk of Hodgkin's disease and other cancers after infectious mononucleosis
.
J Nat Cancer Inst
2000
;
92
:
1522
8
.
78.
Gutensohn (Mueller)
N
,
Shapiro
D
. 
Social class risk factors among children with Hodgkin's disease
.
Int J Cancer
1982
;
30
:
433
5
.
79.
Newell
GR
,
Henderson
BE
. 
Discussion of case–control study of Hodgkin's disease
.
Cancer Res
1974
;
34
:
1169
71
.
80.
Vestergaard
H
,
Westergaard
T
,
Wolfahrt
I
,
Hjalgrim
H
,
Melbye
M
. 
Tonsillitis, tonsillectomy. and Hodgkin's lymphoma
.
Int J Cancer
2010
;
127
:
633
7
.
81.
Mueller
N
,
Swanson
GM
,
Hsieh
CC
,
Cole
P
. 
Tonsillectomy and Hodgkin's disease: results from companion population-based studies
.
J Natl Cancer Inst
1987
;
78
:
1
5
.
82.
Kirchhoff
L
,
Evans
A
,
McClelland
E
,
Carvalho
R
,
Pannuti
C
. 
A case–control study of Hodgkin's disease in Brazil: I. Epidemiologic aspects
.
Am J Epidemiol
1980
;
112
:
595
608
.
83.
Abramson
JH
,
Pridan
H
,
Sacks
MI
,
Avitzour
M
,
Peritz
E
. 
A case–control study of Hodgkin's disease in Israel
.
J Natl Cancer Inst
1978
;
61
:
307
14
.
84.
Johnson
SK
,
Johnson
RE
. 
Tonsillectomy history in Hodgkin's disease
.
N Engl J Med
1972
;
287
:
1122
5
.
85.
Vianna
N
,
Lawerence
C
,
Davies
J
,
Arbuckle
J
,
Harris
S
,
Marani
W
, et al
Tonsillectomy and childhood Hodgkin's disease
.
Lancet
1980
;
2
:
338
40
.
86.
Gallagher
A
,
Perry
J
,
Freeland
J
,
Alexander
F
,
Carman
W
,
Sheild
L
, et al
Hodgkin lymphoma and Epstein–Barr virus (EBV): No evidence to support hit-and-run mechanism in cases classified as non-EBV-associated
.
Int J Cancer
2003
;
104
:
624
30
.
87.
Newell
GR
,
Lynch
HK
,
Gibeau
JM
,
Spitz
MR
. 
Seasonal diagnosis of Hodgkin's disease among young adults
.
J Natl Cancer Inst
1985
;
74
:
53
6
.
88.
Westerbeek
RM
,
Blair
V
,
Eden
OB
,
Kelsey
AM
,
Stevens
RF
,
Will
AM
, et al
Seasonal variations in the onset of childhood leukaemia and lymphoma
.
Br J Cancer
1998
;
78
:
119
24
.
89.
Neilly
IJ
,
Dawson
AA
,
Bennett
B
,
Douglas
S
. 
Evidence for a seasonal variation in the presentation of Hodgkin's disease
.
Leuk Lymphoma
1995
;
18
:
325
8
.
90.
Crump
C
,
Sundquist
J
,
Sieh
W
,
Winkleby
M
,
Sundquist
K
. 
Season of birth and risk of Hodgkin and non-Hodgkin lymphoma
.
Int J Cancer
2014
;
135
:
2735
9
.
91.
Vianna
NJ
,
Polan
AK
,
Keogh
MD
,
Greenwald
P
. 
Hodgkin's disease mortality among physicians
.
Lancet
1974
;
2
:
131
3
.
92.
Grufferman
S
,
Duong
T
,
Cole
P
. 
Occupation and Hodgkin's disease
.
J Natl Cancer Inst
1976
;
57
:
1193
5
.
93.
Jarrett
R
. 
Viruses and Hodgkin's disease (review)
.
Leukemia
1993
;
7
:
S78
82
.
94.
Linabery
A
,
Erhardt
E
,
Fonstad
R
,
Ambinder
R
,
Bunin
G
,
Ross
J
, et al
Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study
.
Int J Cancer
2014
;
135
:
1454
69
.
95.
Tan
M
,
Jiang
X
. 
Histo-blood group antigens: a common niche for norovirus and rotovirus
.
Expert Rev Mol Med
[Internet]. 
2014
:
[10,1017/erm.2014,2 pp.]
.
96.
Nurjadi
D
,
Lependu
J
,
Kremsner
P
,
Zanger
P
. 
Staphylococcus aureus throat carriage is associated with ABO-secretor status
.
J Infect
2012
;
65
:
310
7
.
97.
Makivuokko
H
,
Lahtinen
S
,
Wacklin
P
,
Tuovinen
E
,
Tenkanen
H
,
Nilkkila
J
, et al
Association between the ABO blood group and the human intestinal microbiota composition
.
BMC Microbiology
[Internet] 
2012
;
12
:
[94 p.]
.
98.
Glaser
SL
,
Lin
RJ
,
Stewart
SL
,
Ambinder
RF
,
Jarrett
RF
,
Brousset
P
, et al
Epstein–Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data
.
Int J Cancer
1997
;
70
:
375
82
.